Literature DB >> 4336104

Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4336104     DOI: 10.2165/00003495-197102020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  92 in total

1.  A non-diuretic benzothiadiazine with anti-hypertensive properties.

Authors:  A A RUBIN; F E ROTH; M M WINBURY
Journal:  Nature       Date:  1961-10-14       Impact factor: 49.962

2.  Pharmacology of diazoxide, an antihypertensive, nondiuretic benzothiadiazine.

Authors:  A A RUBIN; F E ROTH; R M TAYLOR; H ROSENKILDE
Journal:  J Pharmacol Exp Ther       Date:  1962-06       Impact factor: 4.030

3.  Metabolic effects of diazoxide in normal subjects, patients with diabetes mellitus, and patients with organic hypoglycemia.

Authors:  J Steinke; J S Soeldner
Journal:  Ann N Y Acad Sci       Date:  1968-04-11       Impact factor: 5.691

4.  Management of severe hypertension with intravenous injections of diazoxide.

Authors:  W E Miller; R W Gifford; D C Humphrey; D G Vidt
Journal:  Am J Cardiol       Date:  1969-12       Impact factor: 2.778

5.  The role of calcium in the mechanism of the antihypertensive action of diazoxide.

Authors:  A J Wohl; L M Hausler; F E Roth
Journal:  Life Sci       Date:  1968-04-01       Impact factor: 5.037

6.  Hyperosmolar nonketotic coma associated with diazoxide therapy for hypoglycemia.

Authors:  M J Balsam; L Baker; R Kaye
Journal:  J Pediatr       Date:  1971-03       Impact factor: 4.406

7.  Mechanisms of action of diazoxide.

Authors:  W G Blackard; C N Aprill
Journal:  J Lab Clin Med       Date:  1967-06

8.  Importance of dissolution rates in producing effective diazoxide blood levels in man.

Authors:  B Calesnick; B Katchen; J Black
Journal:  J Pharm Sci       Date:  1965-09       Impact factor: 3.534

9.  Stimulation of insulin secretion by theophylline.

Authors:  J R Turtle; G K Littleton; D M Kipnis
Journal:  Nature       Date:  1967-02-18       Impact factor: 49.962

10.  Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.

Authors:  E M Sellers; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1970 Jul-Aug       Impact factor: 6.875

View more
  6 in total

1.  Effect of diazoxide on left ventricular performance in hypertension.

Authors:  P Fiegel; P Limbourg; H Just; K F Lang
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

Review 2.  Pharmacokinetics and response to diazoxide in renal failure.

Authors:  R M Pearson
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

Review 3.  [Islet cell cancer with organic hyperinsulinism. Clinical aspects, diagnosis and therapy].

Authors:  R Wirsching; F Spelsberg; R Landgraf
Journal:  Klin Wochenschr       Date:  1982-08-16

Review 4.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

5.  Use of a simulation model to study the acute haemodynamic effects of diazoxide in man.

Authors:  A O Brubakk; J Bathen
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

6.  The effects of diazoxide on total lung resistance in the anesthetized paralyzed guinea-pig.

Authors:  D F Biggs; M A Peterson
Journal:  Agents Actions       Date:  1980-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.